SERMO Drug Ratings platform houses 3M+ data points — 6 highlights

SERMO, a global physician social network, reported its Drug Ratings platform surpassed 3 million data points.

Advertisement

Here are six highlights.

1. SERMO Drug Ratings allows physicians to share their prescription drug reviews and ratings with each other.

2. The 3 million data points include ratings and comments on 2,100-plus pharmaceutical brands.

3. As of March, the platform held 625,000 individual ratings submitted by physicians.

4. The platform also houses 35,000-plus unique comments on physicians’ opinions on pharmaceuticals.

5. More than 40,000 physicians have submitted ratings and more than 60,000 have leveraged the platform.

6. Eighty-three percent of 2,900 physicians polled by SERMO said the opinion or feedback of another physician changed their view of a drug.

More articles on practice management:
Saving pediatric pain patients from the opioid epidemic
OrthoAtlanta opens 14th location by Atlanta Braves park: 5 notes
Palmetto Bone & Joint opens new $9M outpatient clinic: 4 points

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Practice Management

Advertisement

Comments are closed.